The science of CAR-T Dr Elaine Vickers – improving our knowledge Founder of Science Communicated Ltd

Demystifying the patient pathway Genevieve French, CAR-T CNS, King’s College Hospital

UK patient data Dr Andrea Kuhnl, Consultant Haematologist, King’s College Hospital

Palliative care and CAR-T: an integrated approach Maria Mazza-Beange, University Hospitals Bristol

AHP pathways in CAR-T Interviewer: Órla Stewart, Lead Nurse, King’s College Hospital, Aimee Green, Band 7 Physiotherapist CAR-T/Haematology, The Christie, Manchester, Hannah Winn, Senior Specialist Oncology Dietician, The Christie, Manchester

Managing toxicities: case reviews Rose Ellard, Royal Marsden Hospital

Long term follow-up in the CAR-T patient population Órla Stewart, King’s College Hospital

Patient Perspectives: Interview from Manchester Sophie Mulligan, Patient, Rita Angelica, CNS, The Christie, Manchester

Panel discussion: Órla Stewart, Rose Ellard, Sophie Mulligan, Rita Angelica

Addressing the psychological needs of the CAR-T patient Dr Justin Grayer, Consultant Psychologist and
Psychosexual Therapist, Lead for Adult Psychological Support, Royal Marsden Hospital

Patient Perspectives: Interview from Bristol Kenneth Nottage, Patient Maria Mazza-Beange, University Hospitals Bristol

Insights from an Expert Panel: Órla Stewart, Rose Ellard, Maria Mazza-Beange, Andrea Kuhnl

Registration is free of charge

HITT + VITT
Dr Will Lester, Queen Elizabeth Hospital

Laboratory testing for VITT and monitoring of Argatroban and Fondaparinux
Dr Steve Kitchen, Sheffield Haemophilia and Thrombosis Centre

Thrombocytopenic thrombosis – ITP
Dr Gary Benson, Belfast Health and Social Care Trust

Thrombocytopenic thrombosis – TTP & DIC
Dr Jecko Thachil, Manchester Royal Infirmary

An educational resource from Grifols

Registration is free of charge

Clinical update – update from myeloma trials
Dr Charlotte Pawlyn, Institute of Cancer Research, London

Sequential MRD monitoring in myeloma
Dr Ruth de Tute, HMDS, Leeds

Cellular therapies in myeloma
Dr Frances Seymour, Leeds Teaching Hospitals

Panel discussion

Registration is free of charge

Overview and role of bi-specific antibodies
Dr Will Townsend, UCLH, London

Molecular analysis and classification of lymphoid malignancies
Dr Sharon Barrans, Leeds Teaching Hospitals

Molecular subclusters of follicular lymphoma
Professor Reuben Tooze, HMDS & University of Leeds

Panel discussion

Registration is free of charge

Single high-throughput sequencing panel for use in all haematological malignancies: Leeds HMDS experience
Dr Paul Evans, HMDS, Leeds

Eosinophilia – an update
Professor Nick Cross, University of Southampton

Myeloproliferative neoplasms
Dr Adam Mead, Oxford University Hospitals

Registration is free of charge

This meeting was designed to address the challenges and recurring themes faced by the MDT. Sessions are highly interactive with experts reviewing complex cases and sharing latest data on treatments.

Enjoy the following sessions:

Myeloma: Elderly and relapse
Professor Graham Jackson (Newcastle) and Dr Chris Parrish (Leeds)

Chronic Leukaemia: MDM management dilemmas with front line, relapse and ultra-high risk CLL patients
Dr Piers Patten (London), Dr Helen Marr (Newcastle) and Dr Anne Parker (Glasgow)

AML: Newly diagnosed and who to transplant
Dr Mike Dennis (Manchester), Dr Annie Latif (Glasgow) and Dr Rachel Protheroe (Bristol)

Lymphoma Carousel: MCL CAR T when?, bispecifics when? …and some challenging T cell cases
Prof Tim Illidge (Manchester), Dr Wendy Osborne (Newcastle), Dr Tobias Menne (Newcastle) & Dr Piers Patten (London)

ALL: Hot topics everyone should know & how young is young?
Dr Tobias Menne (Newcastle) and Dr Anna Castleton (Manchester)

MDT Panel: When is allograft appropriate – disease specific discussions
Dr Anne Parker (Glasgow), Dr Wendy Osborne (Newcastle), Prof Graham Jackson (Newcastle), Dr Tobias Menne (Newcastle) and Dr Fiona Dignan (Manchester)

Registration Fee: £60 (£50 + VAT)

An educational resource to accompany the ITP Update Day on Friday 14th May

Registration is free of charge

Prevention and management of complications in transplant
Late effects and long-term survivorship
Professor Navneet Majhail, Cleveland Clinic, USA

Registration is free of charge

Plasma cell dysplasia and CAR-T cell in multiple myeloma
Professor Gordon Cook, University of Leeds

Registration is free of charge

Topic:

Treatment of advanced mycosis fungoides and Sezary syndrome by Dr Stephen Morris,
(supported by Kyowa Kirin)

Registration is free of charge

Topics:

Molecular Diagnostics and Biomarkers: Lymphoma advances
Dr Cathy Burton, Leeds Teaching Hospitals

and

Molecular Diagnostics and Biomarkers: Myeloid advances
Dr Manish Jain, Leeds Teaching Hospitals

Registration is free of charge

Topics include:

Future of antimicrobials for haematology patients
Dr Jessica Martin, Consultant Microbiologist, Leeds Teaching Hospitals

Supported by an educational resource from Mallinckrodt, who have had no input into the choice of speakers or content of the video, as part of the Transplant Complications and GVHD meeting

Registration is free of charge

Topics include:

Transplants for bone marrow failure disorders
Dr Catherine Flynn, St James’ Hospital, Dublin

Supported by an educational resource from Mallinckrodt, who have had no input into the choice of speakers or content of the video, as part of the Transplant Complications and GVHD meeting

Registration is free of charge

Topics include:

Chronic GVHD (mucosal, genital and ophthalmic) – management and outcome data
Dr Arun Alfred, Rotherham District General Hospital

Lung GVHD
Dr Muhammad Qasim, Consultant in Respiratory Medicine, Manchester University Hospitals

Supported by an educational resource from Mallinckrodt, who have had no input into the choice of speakers or content of the video, as part of the Transplant Complications and GVHD meeting

Registration is free of charge

Topics include:

Options in standard front line therapy in AML
Dr Priyanka Mehta, Bristol

Strategies to managing relapse in AML
Dr Mike Dennis, Manchester

Registration is free of charge

Topics include:

Venetoclax as a potential game-changer in the management of older (and younger) adults with AML
Professor Andrew Wei, Melbourne, Australia

Advances in the management of APML
Professor Uwe Platzbecker, Leipzig, Germany

Registration is free of charge

Topics include:

Novel therapeutic strategies in relapsed AML
Professor Paresh Vyas, Oxford and Dr Victoria Potter, London

Emerging molecular and immune therapies in AML
Professor Naval Daver, MD Anderson, Texas

Registration is free of charge

Topics include:

Biological aspects of smouldering myeloma
Professor Kwee Yong, UCLH

Clinical aspects of smouldering myeloma
Dr Marquita Camilleri, UCLH

Registration is free of charge

Topics include:

The ITP Forum – Dr Quentin Hill, Leeds
Real world data for TPO receptor agonists; UK data – Dr Vickie McDonald, London
Real life data for TPO-receptor agonists; French registry – Dr Guillaume Moulis, Toulouse
Thrombosis and ITP – Dr Guillaume Moulis, Toulouse

Registration is free of charge